Atherosclerotic Cardiovascular Disease

PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.

PHILADELPHIA — HDL cholesterol has not been shown to have a causal role in atherosclerotic cardiovascular disease, nor has lowering it reduced CV outcomes, but it may serve as a marker for CVD risk, according to a speaker.

PHILADELPHIA — In this Healio video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, presents updated multispecialty practice recommendations for diabetes, cardiorenal and metabolic diseases at the Heart in Diabetes CME Conference.

Roche announced its lipoprotein(a) assay received breakthrough device designation from the FDA to identify patients with history of atherosclerotic CVD who may benefit from Lp(a)-lowering therapy currently in development.

Disruptions in endothelial function caused by brief bouts of elicited anger may be an early predictor of heart disease, but the underlying mechanism remains unclear, researchers reported.

ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from the ROSE2 trial.

ATLANTA — In a study of behavioral economics, researchers reported benefits of gamification and money incentives to boost daily step count for patients at high risk for CVD.

Patients with autoimmune blistering disorders had elevated cardiovascular risks, including for atherosclerotic cardiovascular disease, heart failure, arrhythmia, venous thromboembolism and death, according to a study.

Artificial intelligence analysis of a single chest radiograph may predict 10-year CVD risk beyond the traditional atherosclerotic CVD risk calculator, even among individuals with missing electronic medical record data, researchers reported.

In a cohort of American Indian individuals, more than 70% of young adults and more than 50% of adolescents had dyslipidemia, and some had subclinical or clinical heart disease, according to new data from the Strong Heart Study.